Cite
HARVARD Citation
Derache, A. et al. (2019). Predicted antiviral activity of tenofovir versus abacavir in combination with a cytosine analogue and the integrase inhibitor dolutegravir in HIV-1-infected South African patients initiating or failing first-line ART. Journal of antimicrobial chemotherapy. pp. 473-479. [Online].